Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Amgen reveals polypeptide KGF analogues

June 14, 1996

Excellent preclinical results of Repel announced

June 14, 1996

New topical corticosteroids from Hoechst

June 14, 1996

Favorable trial results with interferon gamma-1b for atopic dermatitis and keloids

June 7, 1996

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

June 7, 1996

Synthetic retinoid analogue cleared for U.S. market

June 7, 1996

Oclassen obtains rights to 5-MOP

June 7, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

Efficacy of Peptide Technology's oral psoriasis treatment confirmed

May 31, 1996

Amlexanox approvable in U.S.

May 24, 1996

Popular Stories

Free access to BioWorld coronavirus articles
BioWorld
The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
Today's news in brief
BioWorld
BioWorld briefs for Nov. 30, 2022.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 30, 2022.
Innovent bolsters case for hypercholesterolemia MAb with phase III results
BioWorld
Innovent Biologics Inc. said that, compared to a placebo, both doses of its anti-PCSK-9 monoclonal antibody tafolecimab tested in a phase III trial “yielded...
FDA briefing papers indicate few qualms for Veru’s COVID-19 therapy
BioWorld
Briefing documents related to the Nov. 9 meeting of the U.S. FDA’s Pulmonary-Allergy Drugs Advisory Committee augur well for Veru Pharmaceuticals Inc.’s request...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.